Last 12 months
Inside the activity.
0 purchase rows · 240 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 200 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 31 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 27, 2019 Filed Dec 2, 2019 18:40 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 48,953 | $117.51 | $5,752,256.53 |
DisclosureSEC source: 0001209191-19-058461 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,430,304 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.50 to $117.63, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 15:40 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 56,729 | $117.81 | $6,683,470.41 |
DisclosureSEC source: 0001209191-19-058247 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,479,257 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.50 to $118.08, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 16:19 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 109,318 | $117.60 | $12,855,796.80 |
DisclosureSEC source: 0001209191-19-058044 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,535,986 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.50 to $118.25, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| November 22, 2019 Filed Nov 25, 2019 21:29 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 222,577 | $116.31 | $25,888,821.18 |
DisclosureSEC source: 0001209191-19-057936 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,645,304 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.00 to $116.62, inclusive. Read SEC document |
| November 22, 2019 Filed Nov 25, 2019 21:29 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 29,159 | $115.74 | $3,374,775.18 |
DisclosureSEC source: 0001209191-19-057936 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,867,881 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.00 to $115.995, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| November 21, 2019 Filed Nov 22, 2019 15:56 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 108,264 | $115.14 | $12,465,506.13 |
DisclosureSEC source: 0001209191-19-057722 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,897,040 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.00 to $115.51, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| November 19, 2019 Filed Nov 20, 2019 15:17 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 18,783 | $115.74 | $2,173,869.29 |
DisclosureSEC source: 0001209191-19-057390 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,005,304 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.50 to $116.12, inclusive. Read SEC document |
| November 19, 2019 Filed Nov 20, 2019 15:17 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 186,217 | $114.99 | $21,412,906.61 |
DisclosureSEC source: 0001209191-19-057390 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,024,087 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.50 to $115.49, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| November 18, 2019 Filed Nov 19, 2019 17:00 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 10,598 | $114.00 | $1,208,172.00 |
DisclosureSEC source: 0001209191-19-057090 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,210,304 Read SEC document |
| November 18, 2019 Filed Nov 20, 2019 18:08 UTC |
TAI JACKSON PDirector
|
GrantCommon Stock | 1,552 | $114.07 | $177,036.64 |
DisclosureSEC source: 0000059478-19-000304 · wf-form4_157427330098271.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,992 Read SEC document |
| November 18, 2019 Filed Nov 20, 2019 18:09 UTC |
SEIFERT KATHI PDirector
|
GrantCommon Stock | 1,534 | $114.07 | $174,983.38 |
DisclosureSEC source: 0000059478-19-000305 · wf-form4_157427336790478.xml · nonDerivative · entry 1 SEIFERT KATHI P · CIK 0001222893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,337 Read SEC document |
| November 18, 2019 Filed Nov 20, 2019 18:10 UTC |
Runge Marschall SDirector
|
GrantCommon Stock | 1,534 | $114.07 | $174,983.38 |
DisclosureSEC source: 0000059478-19-000306 · wf-form4_157427343481509.xml · nonDerivative · entry 1 Runge Marschall S · CIK 0001586197 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,779 Read SEC document |
| November 18, 2019 Filed Nov 20, 2019 18:12 UTC |
LUCIANO JUAN RDirector
|
GrantCommon Stock | 1,653 | $114.07 | $188,557.71 |
DisclosureSEC source: 0000059478-19-000307 · wf-form4_157427352080228.xml · nonDerivative · entry 1 LUCIANO JUAN R · CIK 0001455792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,991 Read SEC document |
| November 18, 2019 Filed Nov 20, 2019 18:13 UTC |
JACKSON JAMEREDirector
|
GrantCommon Stock | 1,534 | $114.07 | $174,983.38 |
DisclosureSEC source: 0000059478-19-000308 · wf-form4_157427359812880.xml · nonDerivative · entry 1 JACKSON JAMERE · CIK 0001601813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,629 Read SEC document |
| November 18, 2019 Filed Nov 20, 2019 18:14 UTC |
Kaelin William G JrDirector
|
GrantCommon Stock | 1,534 | $117.07 | $179,585.38 |
DisclosureSEC source: 0000059478-19-000309 · wf-form4_157427368387762.xml · nonDerivative · entry 1 Kaelin William G Jr · CIK 0001551715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,139 Read SEC document |
| November 18, 2019 Filed Nov 20, 2019 18:16 UTC |
Fyrwald J ErikDirector
|
GrantCommon Stock | 1,534 | $114.07 | $174,983.38 |
DisclosureSEC source: 0000059478-19-000310 · wf-form4_157427376125830.xml · nonDerivative · entry 1 Fyrwald J Erik · CIK 0001343564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,254 Read SEC document |
| November 18, 2019 Filed Nov 20, 2019 18:23 UTC |
ESKEW MICHAEL LDirector
|
GrantCommon Stock | 1,534 | $114.07 | $174,983.38 |
DisclosureSEC source: 0000059478-19-000311 · wf-form4_157427419709369.xml · nonDerivative · entry 1 ESKEW MICHAEL L · CIK 0001227734 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,610 Read SEC document |
| November 18, 2019 Filed Nov 20, 2019 18:24 UTC |
Bertozzi Carolyn RDirector
|
GrantCommon Stock | 1,534 | $114.07 | $174,983.38 |
DisclosureSEC source: 0000059478-19-000312 · wf-form4_157427426436856.xml · nonDerivative · entry 1 Bertozzi Carolyn R · CIK 0001698766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,905 Read SEC document |
| November 18, 2019 Filed Nov 20, 2019 18:25 UTC |
Baicker KatherineDirector
|
GrantCommon Stock | 1,534 | $114.07 | $174,983.38 |
DisclosureSEC source: 0000059478-19-000313 · wf-form4_157427432918762.xml · nonDerivative · entry 1 Baicker Katherine · CIK 0001537067 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,687 Read SEC document |
| November 18, 2019 Filed Nov 20, 2019 18:27 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 1,630 | $114.07 | $185,934.10 |
DisclosureSEC source: 0000059478-19-000314 · wf-form4_157427441081541.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,580 Read SEC document |
| November 18, 2019 Filed Nov 20, 2019 18:29 UTC |
Walker KarenDirector
|
GrantCommon Stock | 1,687 | $114.07 | $192,436.09 |
DisclosureSEC source: 0000059478-19-000316 · wf-form4_157427456956968.xml · nonDerivative · entry 1 Walker Karen · CIK 0001642519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,834 Read SEC document |
| November 12, 2019 Filed Nov 13, 2019 18:53 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 7,981 | $114.00 | $909,841.18 |
DisclosureSEC source: 0001209191-19-056299 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,220,902 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.00 to $114.02, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| November 11, 2019 Filed Nov 12, 2019 18:12 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 100 | $114.07 | $11,406.50 |
DisclosureSEC source: 0001209191-19-055942 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,228,883 Read SEC document |
| November 07, 2019 Filed Nov 8, 2019 15:35 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 400 | $114.37 | $45,749.00 |
DisclosureSEC source: 0001209191-19-055761 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,228,983 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.235 to $114.45, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| November 06, 2019 Filed Nov 7, 2019 16:03 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 173,918 | $114.05 | $19,835,000.06 |
DisclosureSEC source: 0001209191-19-055605 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,229,383 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.00 to $114.26, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| November 04, 2019 Filed Nov 5, 2019 18:18 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 7,003 | $114.04 | $798,608.11 |
DisclosureSEC source: 0001209191-19-055125 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,403,301 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.00 to $114.115, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 14:37 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 7,593 | $114.55 | $869,808.52 |
DisclosureSEC source: 0001209191-19-054683 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,410,304 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.50 to $114.64, inclusive. F2 · balance_after: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.50 to $114.64, inclusive. Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 14:37 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 182,407 | $113.98 | $20,789,837.83 |
DisclosureSEC source: 0001209191-19-054683 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,417,897 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.50 to $114.49, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. F1 · balance_after: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.50 to $114.49, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| October 30, 2019 Filed Dec 10, 2019 16:56 UTC |
O'Neill MylesSVP & Pres., Mfg. Operations
|
GiftCommon Stock | 222 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-19-000320 · wf-form4_157599695974979.xml · nonDerivative · entry 3 O'Neill Myles · CIK 0001725140 · SVP & Pres., Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,424 Read SEC document |
| October 25, 2019 Filed Oct 25, 2019 16:13 UTC |
Ricks David ADirector · President & CEO
|
PurchaseCommon Stock | 4,615 | $108.38 | $500,173.70 |
DisclosureSEC source: 0000059478-19-000282 · wf-form4_157201996825684.xml · nonDerivative · entry 1 Ricks David A · CIK 0001538604 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,405 Read SEC document |
| October 25, 2019 Filed Oct 28, 2019 19:00 UTC |
Skovronsky DanielSVP, CSO, and Pres. LRL
|
PurchaseCommon Stock | 5,000 | $108.61 | $543,050.00 |
DisclosureSEC source: 0000059478-19-000285 · wf-form4_157228915675728.xml · nonDerivative · entry 1 Skovronsky Daniel · CIK 0001741474 · SVP, CSO, and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,818 Read SEC document |
| October 25, 2019 Filed Oct 28, 2019 19:06 UTC |
Smiley Joshua LSVP and CFO
|
PurchaseCommon Stock | 929 | $107.59 | $99,951.11 |
DisclosureSEC source: 0000059478-19-000287 · wf-form4_157228954632294.xml · nonDerivative · entry 1 Smiley Joshua L · CIK 0001725189 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,524 Read SEC document |
| October 25, 2019 Filed Oct 28, 2019 19:11 UTC |
White Anne E.SVP & Pres-Lilly Oncology
|
PurchaseCommon Stock | 1,000 | $108.84 | $108,840.00 |
DisclosureSEC source: 0000059478-19-000289 · wf-form4_157228979250811.xml · nonDerivative · entry 1 White Anne E. · CIK 0001752313 · SVP & Pres-Lilly Oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,043 Read SEC document |
| October 24, 2019 Filed Oct 25, 2019 16:10 UTC |
TAI JACKSON PDirector
|
PurchaseCommon Stock | 1,861 | $107.49 | $200,038.89 |
DisclosureSEC source: 0000059478-19-000280 · wf-form4_157201981981117.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,440 F1 · price: This transaction was executed in multiple trades at prices ranging from $107.45 to $107.55. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 24, 2019 Filed Jan 6, 2020 22:01 UTC |
Harrington Michael JSenior VP and General Counsel
|
GiftCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-20-000002 · wf-form4_157834805509678.xml · nonDerivative · entry 1 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 59,500 F1 · ownership.direct: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| October 21, 2019 Filed Oct 22, 2019 18:19 UTC |
Walker KarenDirector
|
GrantCommon Stock | 115 | $107.91 | $12,409.65 |
DisclosureSEC source: 0000059478-19-000260 · wf-form4_157176834496949.xml · nonDerivative · entry 1 Walker Karen · CIK 0001642519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,170 Read SEC document |
| October 21, 2019 Filed Oct 22, 2019 18:21 UTC |
TAI JACKSON PDirector
|
GrantCommon Stock | 18 | $107.91 | $1,942.38 |
DisclosureSEC source: 0000059478-19-000262 · wf-form4_157176846830534.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,579 Read SEC document |
| October 21, 2019 Filed Oct 22, 2019 18:24 UTC |
LUCIANO JUAN RDirector
|
GrantCommon Stock | 126 | $107.91 | $13,596.66 |
DisclosureSEC source: 0000059478-19-000264 · wf-form4_157176862562634.xml · nonDerivative · entry 1 LUCIANO JUAN R · CIK 0001455792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,338 Read SEC document |
| October 21, 2019 Filed Oct 22, 2019 18:26 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 101 | $107.91 | $10,898.91 |
DisclosureSEC source: 0000059478-19-000266 · wf-form4_157176877459800.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,950 Read SEC document |
| October 21, 2019 Filed Nov 20, 2019 18:28 UTC Amendment |
Walker KarenDirector
|
GrantCommon Stock | 92 | $107.91 | $9,927.72 |
DisclosureSEC source: 0000059478-19-000315 · wf-form4a_157427450273032.xml · nonDerivative · entry 1 Walker Karen · CIK 0001642519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,147 F1 · shares: This amendment is being filed to correct the number of securities acquired on the original Form 4 filed October 22, 2019. F2 · balance_after: This amendment is being filed to correct the number of securities beneficially owned following the reported transaction. Read SEC document |
| September 20, 2019 Filed Sep 23, 2019 19:54 UTC |
Zulueta Alfonso GSVP & President, Lilly Int'l
|
SaleCommon Stock | 4,500 | $117.00 | $526,500.00 |
DisclosureSEC source: 0000059478-19-000258 · wf-form4_156926846251839.xml · nonDerivative · entry 1 Zulueta Alfonso G · CIK 0001596336 · SVP & President, Lilly Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,806 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 31, 2019. Read SEC document |
| September 20, 2019 Filed Sep 23, 2019 17:33 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 96,800 | $116.61 | $11,287,848.00 |
DisclosureSEC source: 0001209191-19-050426 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,600,304 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.42 to $117.23, inclusive. F2 · balance_after: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.42 to $117.23, inclusive. Read SEC document |
| September 20, 2019 Filed Sep 23, 2019 17:33 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 113,200 | $116.17 | $13,149,878.00 |
DisclosureSEC source: 0001209191-19-050426 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,697,104 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.42 to $116.415, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. F1 · balance_after: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.42 to $116.415, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 21:10 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 99 | $110.13 | $10,902.87 |
DisclosureSEC source: 0000059478-19-000252 · wf-form4_156875461395000.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,849 Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 21:11 UTC |
Walker KarenDirector
|
GrantCommon Stock | 113 | $110.13 | $12,444.69 |
DisclosureSEC source: 0000059478-19-000253 · wf-form4_156875467553851.xml · nonDerivative · entry 1 Walker Karen · CIK 0001642519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,055 Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 21:12 UTC |
LUCIANO JUAN RDirector
|
GrantCommon Stock | 123 | $110.13 | $13,545.99 |
DisclosureSEC source: 0000059478-19-000254 · wf-form4_156875475186652.xml · nonDerivative · entry 1 LUCIANO JUAN R · CIK 0001455792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,212 Read SEC document |
| September 16, 2019 Filed Sep 18, 2019 14:42 UTC |
TAI JACKSON PDirector
|
GrantCommon Stock | 18 | $110.13 | $1,982.34 |
DisclosureSEC source: 0000059478-19-000256 · wf-form4_156881775017021.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,561 Read SEC document |
| September 05, 2019 Filed Sep 9, 2019 16:12 UTC |
Fry Stephen FSVP, HR & Diversity
|
SaleCommon Stock | 9,452 | $115.00 | $1,086,980.00 |
DisclosureSEC source: 0000059478-19-000248 · wf-form4_156804550932812.xml · nonDerivative · entry 1 Fry Stephen F · CIK 0001513324 · SVP, HR & Diversity 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,211 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 20, 2019. Read SEC document |
| September 03, 2019 Filed Sep 4, 2019 19:09 UTC |
Zulueta Alfonso GSVP & President, Lilly Int'l
|
SaleCommon Stock | 19,500 | $112.91 | $2,201,745.00 |
DisclosureSEC source: 0000059478-19-000242 · wf-form4_156762415693254.xml · nonDerivative · entry 1 Zulueta Alfonso G · CIK 0001596336 · SVP & President, Lilly Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,306 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 31, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $112.54 to $113.85. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 03, 2019 Filed Sep 9, 2019 15:59 UTC Amendment |
Zulueta Alfonso GSVP & President, Lilly Int'l
|
SaleCommon Stock | 4,500 | $112.54 | $506,430.00 |
DisclosureSEC source: 0000059478-19-000246 · wf-form4a_156804473200793.xml · nonDerivative · entry 3 Zulueta Alfonso G · CIK 0001596336 · SVP & President, Lilly Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,306 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 31, 2019. F4 · price: This transaction is being amended to correct the total number of shares and price previously reported as part of multiple trades on the Form 4 filed on 09/04/19. This transaction was executed in one trade at a price of $112.54. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.